Alfresa Holdings Corporation (TYO:2784)
Japan flag Japan · Delayed Price · Currency is JPY
2,320.00
-46.00 (-1.94%)
At close: Dec 5, 2025

Alfresa Holdings Company Description

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally.

It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethical pharmaceuticals wholesaling business; self-medication products wholesaling business; and other medical-related businesses.

In addition, the company manufactures and markets active pharmaceutical ingredients; contract distribution services in hospitals; operation, maintenance, and development of information system; supply of cell raw materials; manufacturing of specific processed cells and regenerative medicine products.

The company was incorporated in 2003 and is based in Tokyo, Japan.

Alfresa Holdings Corporation
Country Japan
Founded 2003
Industry Medical Distribution
Sector Healthcare
Employees 12,452
CEO Ryuji Arakawa

Contact Details

Address:
Ote Center Building
Tokyo, 100-0004
Japan
Phone 81 3 5219 5100
Website alfresa.com

Stock Details

Ticker Symbol 2784
Exchange Tokyo Stock Exchange
Stock Type Common Stock
Fiscal Year April - March
Reporting Currency JPY
ISIN Number JP3126340003
SIC Code 5122

Key Executives

Name Position
Ryuji Arakawa Chief Executive Officer